Cargando…

Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma

BACKGROUND: Targeted arterial infusion of verapamil combined with chemotherapy (TVCC) is an effective clinical interventional therapy for esophageal squamous cell carcinoma (ESCC), but multidrug resistance (MDR) remains the major cause of relapse or poor prognosis, and the underlying molecular mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Qingjie, Wang, Yan, Wu, Qingnan, Li, Xianfeng, Teng, Huajing, Fan, Jiawen, Cao, Yiren, Fan, Pingsheng, Zhan, Qimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492345/ https://www.ncbi.nlm.nih.gov/pubmed/34494553 http://dx.doi.org/10.1172/jci.insight.150203

Ejemplares similares

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)

BAALC‐AS1/G3BP2/c‐Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma
por: Zhang, Hongyue, et al.
Publicado: (2021)

MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2021)

The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2022)

The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma
por: Liu, Xuesong, et al.
Publicado: (2022)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2021)

Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2022)

Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression
por: Wang, Yan, et al.
Publicado: (2023)

Organoid models combined with genome engineering and epigenome studies to define SOX2 function evolution in esophageal squamous cell carcinoma
por: Diao, Fei‐Yu
Publicado: (2021)

Co‐targeting FAK and Gli1 inhibits the tumor‐associated macrophages‐released CCL22‐mediated esophageal squamous cell carcinoma malignancy
por: Chen, Jie, et al.
Publicado: (2023)

Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Liu, Rui, et al.
Publicado: (2020)

Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma
por: Gong, Wei, et al.
Publicado: (2022)

Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)
por: Zhao, Yue, et al.
Publicado: (2014)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma
por: Li, Xiao, et al.
Publicado: (2014)

FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma
por: Wang, Yu, et al.
Publicado: (2019)

CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties
por: Lv, Mengzhu, et al.
Publicado: (2023)

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

miR-875-5p exerts tumor-promoting function via down-regulation of CAPZA1 in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2021)

Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma
por: Guo, Shichao, et al.
Publicado: (2022)

Orbital Metastasis of Esophageal Squamous Cell Carcinoma
por: Iimori, Kei, et al.
Publicado: (2020)

Development and validation of an intensive care unit acquired weakness prediction model: A cohort study
por: Yang, Zi, et al.
Publicado: (2023)

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019)

Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2018)

Editorial: Evolution of crop genomes and epigenomes
por: Du, Hai, et al.
Publicado: (2022)

OncoBase: a platform for decoding regulatory somatic mutations in human cancers
por: Li, Xianfeng, et al.
Publicado: (2019)

Guillain-Barré-Like Syndrome From Esophageal Squamous Cell Carcinoma
por: Jordan, Aryanna, et al.
Publicado: (2022)

Esophageal Squamous Cell Carcinoma with White Globe Appearance
por: Horitani, Shunsuke, et al.
Publicado: (2022)

Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
por: Li, Zhen, et al.
Publicado: (2021)

Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
por: Xu, Yang, et al.
Publicado: (2014)

Effect of anesthesia assistance on the detection rate of precancerous lesions and early esophageal squamous cell cancer in esophagogastroduodenoscopy screening: A retrospective study based on propensity score matching
por: Liang, Min, et al.
Publicado: (2023)

Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment
por: Zhao, Zitong, et al.
Publicado: (2023)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2019)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2021)

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer
por: Wang, Guangchao, et al.
Publicado: (2020)

Downregulation of Ubiquitin Inhibits the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
por: Gao, Yi, et al.
Publicado: (2020)

A likelihood approach to testing hypotheses on the co-evolution of epigenome and genome
por: Lu, Jia, et al.
Publicado: (2018)

HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma–in vivo and vitro
por: He, Xing, et al.
Publicado: (2023)

Sequence-Level Mechanisms of Human Epigenome Evolution
por: Prendergast, James G.D., et al.
Publicado: (2014)

The co-evolution of the genome and epigenome in colorectal cancer
por: Heide, Timon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fa94d42om09bmbbdt7f5omaq2s